Cirrhotic ascites: A review of management

Hospital Medicine

Volumn 65, Issue 1, 2004, Pages 22-26

  Sivayokan, Tharshanan ^a   Dillon, John F ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; AMILORIDE; FUROSEMIDE; SPIRONOLACTONE; TRIAMTERENE;

ASCITES; CHYLOUS ASCITES; GYNECOMASTIA; HEPATORENAL SYNDROME; HUMAN; IMPOTENCE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PERITONITIS; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; REVIEW; TREATMENT OUTCOME; VASODILATATION; BACTERIAL INFECTION; METHODOLOGY; MICROBIOLOGY; PARACENTESIS; PERITONEUM VEIN SHUNT; RECURRENT DISEASE; RISK FACTOR;

ASCITES; BACTERIAL INFECTIONS; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PARACENTESIS; PERITONEOVENOUS SHUNT; PERITONITIS; RECURRENCE; RISK FACTORS;

EID: 1542377995     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2004.65.1.2414     Document Type: Review

References (18)

1. Altman C, Grange JD, Amiot X et al (1995) Survival after a first episode of spontaneous bacterial peritonitis: prognosis of potential candidates for orthoptic liver transplantation. J Gastroenterol Hepatol 10: 47-50
2. Arroyo V, Gines P, Gerbes AL et al (1996) Definitions and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 23: 164-76
3. Brensing KA, Textor J, Perz J et al (2000) Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 47: 288-95
4. D'Amico G, Morabito A, Pagliaro L et al (1986) Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 31: 468-75
5. Gines P, Rimola A, Planas R et al (1990) Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo controlled trial. Hepatology 12: 716-24
6. Gines A, Escorsell A, Gines P et al (1993) Incidence, predictive factors and prognosis of hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 105: 229-36
7. Gines P, Uriz J, Calahorra B et al (2002) Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 123(6): 1839-47
8. Holt S, Goodier D, Marley R et al (1999) Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet 353: 294-5
9. Lebrec D, Giuily N, Hadengue A et al (1996) Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol 25: 135-44
10. Perez-Ayuso RM, Arroyo V, Planas R et al (1983) Randomized comparative study of efficacy of furosemide vs. spironolactone in non-azotemic cirrhotic ascites. Gastroenterology 84: 961-8
11. Planas R, Gines P, Arroyo V et al (1990) Dextran 70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Gastroenterolgy 99: 1736-44
12. Rimola A, Garcia-Tsao G, Navasa M et al (2000) Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 32(1): 142-53
13. Rossle M, Ochs A, Gulberg V et al (2000) A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 342: 1701-7
14. Runyon BA (1986) Low-protein-concentration ascitic fluid is predisposition to spontaneous bacterial peritonitis. Gastroenterology 91: 1343-6
15. Runyon BA, McHutchison JG, Antillen MR, Akriviadis EA, Montano AA (1991) Short-course vs long-course antibiotic treatment of spontaneous bacterial peritonitis: a randomised control trial of 100 patients. Gastroenterology 100: 1737-42
16. Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, McHutchinson JG (1992) The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med 117: 215-20
17. Schrier RW, Arroyo V, Bernadi M, Epstein M, Henriksen JH, Rodés J (1988) Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8: 1151-7
18. Uriz J, Gines P, Cardenas A et al (2000) Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J Hepatology 33: 43-8